ENTITY
Novartis AG Reg

Novartis AG Reg (NOVN VX)

40
Analysis
Health CareSwitzerland
Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company uses innovative science and digital technologies to create transformative treatments in areas of great medical need. Novartis offers patent protected prescription medicine and generic pharmaceuticals and biosimilars.
more
Refresh
bullishSingtel
02 May 2022 05:02

MSCI ACWI, ACWI Ex-US, EM Testing Logical Support; Actionable Themes: Defensives & Reopening Stocks

We are testing the March lows in several global indexes, including the MSCI $ACWI, ACWI ex-US $ACWX, and EM $EEM. While this is a logical spot for...

Logo
408 Views
Share
bullishNovartis AG Reg
15 Mar 2021 21:49Issuer-paid

Video: Cantargia - executive interview

Cantargia is a clinical-stage biotechnology company based in Sweden, established in 2009 and listed on the Nasdaq Stockholm main market. It is...

Share
bullishAstraZeneca PLC
23 Feb 2021 22:39Issuer-paid

Video: Oxford Biomedica – executive interview

Why are investors buying into Oxford Biomedica (LN:OXB)? In this interview, BBC broadcaster Vivienne Parry OBE asks CEO John Dawson why Oxford...

Share
bullishBeiGene
13 Jan 2021 02:26

BeiGene: Novartis Grabs Tislelizumab Rights

BeiGene's deal with Novartis for PD-1 tislelizumab validates its competitive position, and marks a rising trend of Chinese companies licensing...

Share
02 Dec 2020 09:36

Harbour Biomed IPO: Positive Thoughts in Brief

This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.

Share
x